BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9450860)

  • 1. Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.
    DudokdeWit AC; Tibben A; Duivenvoorden HJ; Niermeijer MF; Passchier J; Trijsburg RW
    Am J Med Genet; 1998 Jan; 75(1):62-74. PubMed ID: 9450860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.
    DudokdeWit AC; Tibben A; Duivenvoorden HJ; Frets PG; Zoeteweij MW; Losekoot M; van Haeringen A; Niermeijer MF; Passchier J
    J Med Genet; 1997 May; 34(5):382-90. PubMed ID: 9152835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
    DudokdeWit AC; Tibben A; Duivenvoorden HJ; Niermeijer MF; Passchier J
    J Med Genet; 1998 Sep; 35(9):745-54. PubMed ID: 9733033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of distress experienced by persons at risk for an autosomal dominant inheritable disorder participating in a predictive testing program: an explorative study. Rotterdam/Leiden Genetics Workgroup.
    Dudok deWit AC; Duivenvoorden HJ; Passchier J; Niermeijer MF; Tibben A
    Psychosom Med; 1998; 60(5):543-9. PubMed ID: 9773756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychological distress in women at risk of hereditary breast/ovarian or HNPCC cancers in the absence of demonstrated mutations.
    Geirdal AØ; Reichelt JG; Dahl AA; Heimdal K; Maehle L; Stormorken A; Møller P
    Fam Cancer; 2005; 4(2):121-6. PubMed ID: 15951962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Attachment Style and Emotion Regulation Strategies Indicate Distress in Predictive Testing?
    van der Meer LB; van Duijn E; Giltay EJ; Tibben A
    J Genet Couns; 2015 Oct; 24(5):862-71. PubMed ID: 25641254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
    Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
    J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological consequences of predictive genetic testing: a systematic review.
    Broadstock M; Michie S; Marteau T
    Eur J Hum Genet; 2000 Oct; 8(10):731-8. PubMed ID: 11039571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Perception and Psychological Distress in Genetic Counselling for Hereditary Breast and/or Ovarian Cancer.
    Cicero G; De Luca R; Dorangricchia P; Lo Coco G; Guarnaccia C; Fanale D; Calò V; Russo A
    J Genet Couns; 2017 Oct; 26(5):999-1007. PubMed ID: 28283917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of genetic testing and pre-test levels of mental distress in Norwegian families with known BRCA1 mutations.
    Reichelt JG; Dahl AA; Heimdal K; Møller P
    Dis Markers; 1999 Oct; 15(1-3):139-43. PubMed ID: 10595268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample.
    Caruso A; Vigna C; Maggi G; Sega FM; Cognetti F; Savarese A
    J Exp Clin Cancer Res; 2008 Nov; 27(1):75. PubMed ID: 19025627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive genetic testing in children and adults: a study of emotional impact.
    Michie S; Bobrow M; Marteau TM
    J Med Genet; 2001 Aug; 38(8):519-26. PubMed ID: 11483640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological distress in the 5-year period after predictive testing for Huntington's disease.
    Decruyenaere M; Evers-Kiebooms G; Cloostermans T; Boogaerts A; Demyttenaere K; Dom R; Fryns JP
    Eur J Hum Genet; 2003 Jan; 11(1):30-8. PubMed ID: 12529703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to facilitate psychosocial adjustment in women tested for hereditary breast or ovarian cancer susceptibility? Insights from network analysis.
    Brédart A; Dick J; Cano A; Robieux L; De Pauw A; Schmutzler R; Stoppa-Lyonnet D; Dolbeault S; Kop JL
    Psychooncology; 2020 Mar; 29(3):550-556. PubMed ID: 31823434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
    Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
    JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.
    Eijzenga W; Bleiker EM; Hahn DE; Kluijt I; Sidharta GN; Gundy C; Aaronson NK
    Psychooncology; 2014 Aug; 23(8):862-9. PubMed ID: 24443031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
    Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
    Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer.
    Nordin K; Lidén A; Hansson M; Rosenquist R; Berglund G
    J Med Genet; 2002 Sep; 39(9):689-94. PubMed ID: 12205115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.